Alsterpaullone, Avotaciclib, Fostamatinib, and Naringin demonstrated acceptable inhibitory effects on both CDK1 and WEE1 proteins, suggesting potential for synergistic control of cancer cell proliferation. This evidence concerns the gene WEE1 and cancer.